Exagen (XGN) Treasury Shares (2021 - 2026)

Exagen has reported Treasury Shares for 6 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 16.85% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 16.85% YoY), and the FY2025 full-year result was $1.8 million, up 4.99% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.1 million, up from $1.8 million in the prior quarter.
• The five-year high for Treasury Shares was $2.1 million in Q1 2026, with the low at $784940.0 in Q2 2022.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.7 million in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 374.91% — and 2025, when it slipped 2.52%.
• Exagen's Treasury Shares stood at $1.0 million in 2022, then jumped by 33.9% to $1.4 million in 2023, then increased by 23.27% to $1.7 million in 2024, then advanced by 4.99% to $1.8 million in 2025, then increased by 18.6% to $2.1 million in 2026.
• The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.